How does tirzepatide ordering work on PeakLifeRx?

PeakLifeRx is a technology-enabled procurement platform connecting clinics to FDA-registered 503B outsourcing facilities. All GLP-1 products it lists come from 503B outsourcing facilities under cGMP standards — not patient-specific 503A compounders. After FDA removed tirzepatide from the shortage list in late 2024, 503B outsourcing facilities generally lost the shortage-list authority to compound tirzepatide for clinic stock. Whether PeakLifeRx's current 503B network still compounds tirzepatide and under what FDA pathway is not confirmed on peakliferx.com — ask directly before designing a program around the assumption.

This matters more for tirzepatide than for most molecules because the program economics are step-sensitive. Tirzepatide titrates across a wide dose range, and landed cost can shift at each step, so you need to model margin step by step — not off a blended quote from a catalog that may no longer be available. Fizy Health routes patient-specific tirzepatide to LegitScript-certified 503A partners, shows resolved per-vial cost at each step before checkout, and validates the entire cart before payment so a wrong vial for the step never becomes a paid rejection.

Three pitfalls define tirzepatide ordering today. The first is supply certainty post-shortage-resolution: confirm whether PeakLifeRx's 503B partners can still compound tirzepatide and under what FDA authority. The second is per-step pricing opacity: PeakLifeRx's public FAQ directs clinics to a custom quote, so you cannot model tirzepatide margin at each dose step until a sales conversation — when a protocol spans a wide range, one blended quote can hide where the program loses money. The third is patient-specificity: PeakLifeRx's 503B model centers clinic bulk supply, not named-patient 503A lines with per-line HIPAA audit.

Fizy Health addresses the second and third directly. Per-vial 503A cost shows on each tirzepatide line before checkout so you can price every protocol step on a real number. The whole refill day goes into one validated clinic cart; steady patients move to auto-ship; cart validation catches step-vial mismatches, licensure gaps, and SIG errors before payment. Where PeakLifeRx's 503B tirzepatide availability is uncertain, that is the first question to confirm — not an assumption.